中山经常便血中山什么原因导致便血,中山治疗痔疮医院哪家好,中山怎么才知道是痔疮,中山大便出黑血是什么原因,中山做完痔疮手术多久能恢复,中山华都肛肠医院在什么路怎么样,中山肛肠医院在那个位置

JOHNSON COUNTY, Kansas — Roughly 5,000 mail-in ballots will be tabulated in Johnson County Friday.The results from the mail-in ballots will be released beginning at 8 a.m. and continue until 5 p.m.The ballots could widen the margin between the two leading Republican primary candidates for governor: Secretary of State Kris Kobach and Gov. Jeff Colyer.When polls closed on Tuesday, slow reporting in Johnson County delayed results. Once the numbers came out the following morning, Kobach led by fewer than 200 votes.Since then, the numbers have been contested, but a 41 Action News county-by-county tally shows Kobach still in the lead.The Secretary of State’s office said it should have all the advance ballots that were mailed in, and any other unofficial election results that were not previously reported on election day.Provisional ballots will be reviewed and counted next week by individual counties. They must certify the results between Monday, Aug. 13 and Monday, Aug. 20.Colyer has asked Kobach to recuse himself from giving local election officials advice. 1081

Just in time to bring some color to holiday tables this winter, pink pineapples. No, they are not yellow pineapples dyed pink. They are pink pineapples that are grown that color.Del Monte has been working on the Pinkglow Pineapple since 2005 and announced they are now for sale.The food company, known for those little fruit cups, says the Pinkglow Pineapple is juicier and sweeter than normal pineapples, and takes 2 years to grow in the jungle in Costa Rica.They are hand-picked in what Del Monte calls “ultra-limited harvests, uniquely and specially grown by the expert growers.” They arrive without their crown; Del Monte farmers remove it to replant in order to cultivate the next crop.That might be why they cost each.“As a leading supplier of fresh pineapples throughout the world, Fresh Del Monte is committed to continuing to invest in our pineapple research and development program to meet the ever-changing needs of our consumers,” said Pablo Rivero, vice president marketing North America, Fresh Del Monte, in a company statement. 1055

LA JOLLA (CNS) - A 31-year-old woman was hospitalized this morning with a fractured neck sustained in a two-vehicle crash at a La Jolla intersection.The woman was driving a 2015 Toyota Prius eastbound in the 8500 block of Whale Watch Way at 4:15 p.m. Friday when she ran a stop sign at Prestwick Drive and made a left turn where a 44-year-old man driving a 2018 Chevy Traverse northbound on Prestwick Drive broadsided the woman's car, according to Officer John Buttle with the San Diego Police Department.The woman was taken to a hospital with a fractured neck, police said. Alcohol was considered a factor in the crash. No arrests were reported. 654

JAMUL (CNS) - A fire of unknown origin damaged a home in a back-country neighborhood west of Barrett Lake today and left a resident with burn injuries.The blaze in the 17000 block of Lyons Valley Road in Jamul erupted shortly before 3 p.m., according to Cal Fire.It took crews about an hour to fully subdue the flames, said Issac Sanchez, a fire captain with the state agency.Medics took a 25-year-old man to UCSD Medical Center in San Diego for treatment of burns of undisclosed severity.The cause of the fire was under investigation, Sanchez said. 557

LA JOLLA (KGTV): Researchers at the UC San Diego Moores Cancer Center and the La Jolla Institute of Allergy and Immunology have teamed up to find a new way to fight cancer.They've created a vaccine that can help teach the immune system how to attack only cancer cells and leave the rest of the body alone."Patients will be able to tolerate their therapy much better than they have so far on conventional approaches," says Dr. Stephen Schoenberger from the La Jolla Institute.Each vaccine is highly personalized to the patient. According to a release from UC San Diego, the vaccines "defines the neoantigens – foreign protein fragments recognized by the immune system – in a patient’s cancer. With neoantigens identified, the team can identify peptides – strings of amino acids – that can be used to create a vaccine to stimulate a protective immune system response."Simply put, the new vaccine takes information from a patient's immune system and the tumor and uses it to help white blood cells to fight it."We're giving them life and giving them hope," says Dr. Schoenberger.The first patient in the clinical trial is Tamara Strauss. She was diagnosed with pancreatic cancer in 2015 and went through chemotherapy and surgery."It was brutal," says Strauss. "It's been three and a half years of hell."Strauss' parents helped fund the clinical trial with a million donation. She says she feels fortunate they could do that, but also hopeful that it helps others down the road."I really pray that this vaccine and personalized form of treatment really does change the paradigm of cancer treatment," says Strauss.During the trial, ten patients will get three doses of the vaccine. They'll also be on Keytruda, an immune system boosting drug for up to two years. Their health will be monitored for five years to determine the vaccine's effectiveness. 1871